AC
ELAN icon

Aristides Capital’s Elanco Animal Health ELAN Stock Holding History

Aristides Capital’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,966
Closed -$220K – 193
2022
Q4 		$220K Buy
+17,966
New +$224K 0.11% 159

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Aristides Capital's ELAN Position: Q1 2023 in Review

Aristides Capital sold out of Elanco Animal Health (ELAN) in Q1 2023, closing a stake of 17,966 shares — an estimated $220K sold.

Aristides Capital first reported a position in ELAN in Q4 2022 and held it in 1 quarter. The position peaked at $220K in Q4 2022. 389 funds tracked by Wall St. Rank hold ELAN as of Q1 2023.

  • Aristides Capital reported no remaining Elanco Animal Health position as of Q1 2023 after selling out during the quarter.
  • Aristides Capital sold 17,966 Elanco Animal Health shares in Q1 2023, an estimated $220K.
  • Aristides Capital first reported a position in Elanco Animal Health in Q4 2022 and held it in 1 quarter.
  • Aristides Capital's Elanco Animal Health position peaked at $220K in Q4 2022.
  • 389 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2023.

Based on Aristides Capital's 13F filing for Q1 2023, filed 12 May 2023.